TRACON Pharmaceuticals Inc (TCON)

TRACON Pharmaceuticals Inc (TCON) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $109,725; returns 1 day -0.3%, 1 week -0.4%, 1 year +3.2%.

TRACON Pharmaceuticals, Inc. is a former clinical-stage biopharmaceutical company that is currently in the process of liquidation and dissolution following the clinical failure of its lead oncology candidate.

Groups TCON belongs to

• Biopharmaceutical
• Clinical Stage
• Biotechnology
• Oncology
• Cancer Therapeutics
• Healthcare
• Life Sciences
• PD-L1

TCON financial model: income statement, cash flow and balance sheet